Statistics

Total Visits

Views
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ?3 circulating tumour cells: the randomised phase III VISNÚ-1 trial74

File Visits

Downloads
35923-233.pdf22

Select a period of time:

Number of views in the range

Views
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ?3 circulating tumour cells: the randomised phase III VISNÚ-1 trial41

Number of downloads in the range

Downloads
35923-233.pdf7

Views

Views
January 20251
February 20250
March 202516
April 202513
May 20255
June 20253
July 20253
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • January 2025
    3
  • February 2025
    2
  • March 2025
    0
  • April 2025
    2
  • May 2025
    0
  • June 2025
    0
  • July 2025
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
Hong Kong11
United States6
Germany3
Austria2
Brazil1
Ecuador1
 

Top countries by downloads

Downloads
United States3
Hong Kong2
 

Top cities views

Views
Hong Kong11
Nuremberg3
Columbus2
Charlotte1
Council Bluffs1
Dallas1
Feliz1
Largo1
Portoviejo1
 

Top cities by downloads

Downloads
Hong Kong2